WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Fulcrum Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FULC annual revenue was $0.0, with -100% growth year-over-year.

FULC past revenue growth

How has FULC's revenue growth performed historically?

Company
-100%
Industry
465.24%
Market
90.32%
FULC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FULC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FULC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FULC revenue history

Current Revenue
$0.0
Current Earnings
-$74.9M
Current Profit Margin
0%

Be the first to know when FULC announces revenue.

FULC Revenue History By Year

FULC Yearly RevenueFULC RevenueFULC ChangeFULC Revenue Growth
2025-12-31$0.00-$80.00M-100.00%
2024-12-31$80.00M$77.20M+2,752.05%
2023-12-31$2.81M-$3.54M-55.77%
2022-12-31$6.34M-$12.82M-66.90%
2021-12-31$19.16M$10.34M+117.19%
2020-12-31$8.82MN/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Fulcrum Therapeutics Revenue FAQ

What was FULC's revenue last quarter?

On Invalid Date, Fulcrum Therapeutics (NASDAQ: FULC) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Fulcrum Therapeutics's revenue was $0.00.

What was Fulcrum Therapeutics's revenue in 2025?

Fulcrum Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a 100% decrease year over year.

How much does Fulcrum Therapeutics make in a day?

Based on Fulcrum Therapeutics annual revenue for the past five years, FULC makes an average of $59,347.95 per day.

What was Fulcrum Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Fulcrum Therapeutics's revenue has grown -100% year over year. This is 565.24 percentage points lower than the US Biotechnology industry revenue growth rate of 465.24%. Fulcrum Therapeutics's revenue in the past year totaled $0.00.

How much does Fulcrum Therapeutics make in a year?

Fulcrum Therapeutics's revenue by year for the past five years is:
  • Fulcrum Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a 100% decrease year over year.
  • Fulcrum Therapeutics's annual revenue for Dec 31, 2024 was $80.00 million, a 2,752.05% increase from 2023.
  • Fulcrum Therapeutics's annual revenue for 2023 was $2.81 million, a 55.77% decrease from 2022.
  • Fulcrum Therapeutics's annual revenue for 2022 was $6.34 million, a 66.9% decrease from 2021.
  • Fulcrum Therapeutics's annual revenue for 2021 was $19.16 million, a 117.19% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.